Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2882 Target Snapshot

Histamine H2 receptor · SINGLE PROTEIN · Cavia porcellus

995Compounds
240Assays
18Approved Drugs
396.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P47747. Use UniProt P47747 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P47747 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histamine H2 receptor as ChEMBL target CHEMBL2882, mapped to UniProt P47747. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histamine H2 receptor
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-14
ChEMBL target ID
CHEMBL2882
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P47747
Histamine H2 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histamine H2 receptor is the right protein anchor across sources, using UniProt P47747 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistamine H2 receptor
UniProt AccessionP47747
Component TypeProtein
Sequence Length359 aa

Histamine H2 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histamine H2 receptor, mapped to UniProt P47747. Sequence length is 359 aa.

Mapped IDP47747
Review nameHistamine H2 receptor
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

18
Approved
5
Phase II
Assay Mix

Activity Type Distribution

IC5026.0
KI58.0
EC50161.0
KD151.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2165630 9.61 EC50 0.2455 Preclinical
CHEMBL2165632 9.41 EC50 0.39 Preclinical
CHEMBL2165628 9.29 EC50 0.51 Preclinical
CHEMBL2165642 9.22 EC50 0.6026 Preclinical
CHEMBL72193 9.15 Ki 0.7079 Preclinical
CHEMBL2165631 9.08 EC50 0.8318 Preclinical
CHEMBL5184911 9.04 EC50 0.912 Preclinical
CHEMBL5206565 8.88 EC50 1.318 Preclinical
CHEMBL2165636 8.87 EC50 1.349 Preclinical
CHEMBL5200771 8.64 EC50 2.291 Preclinical
Distribution

pChEMBL Value Distribution

27
5.0
21
5.5
48
6.0
42
6.5
54
7.0
50
7.5
24
8.0
12
8.5
10
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

HISTAMINE DIHYDROCHLORIDE
CHEMBL1533310
Approved 2008
CLOMIPRAMINE
CHEMBL415
Approved 1989
FAMOTIDINE
CHEMBL902
Approved 1986
RANITIDINE
CHEMBL1790041
Approved 1983
CIMETIDINE
CHEMBL30
Approved 1977
AMITRIPTYLINE
CHEMBL629
Approved 1961
HISTAMINE
CHEMBL90
Approved 1939
Assay Landscape

Assay Landscape

240
Total Assays
222
Tested Compounds
2
Assay Types
Functional — 176 assays, 222 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 133 146 6.8
assay format 36 36 5.6
cell-based format 7 40 8.0
Binding — 64 assays, 108 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 35 54 5.2
single protein format 24 41 6.5
cell-based format 3 5 7.5
cell membrane format 2 8 8.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine